Congenital lipodystrophy induces severe osteosclerosis.
Wei ZouNidhi RohatgiJonathan R BrestoffYan ZhangErica L SchellerClarissa S CraftMichael D BrodtNicole MigotskyMatthew J SilvaCharles A HarrisSteven L TeitelbaumPublished in: PLoS genetics (2019)
Berardinelli-Seip congenital generalized lipodystrophy is associated with increased bone mass suggesting that fat tissue regulates the skeleton. Because there is little mechanistic information regarding this issue, we generated "fat-free" (FF) mice completely lacking visible visceral, subcutaneous and brown fat. Due to robust osteoblastic activity, trabecular and cortical bone volume is markedly enhanced in these animals. FF mice, like Berardinelli-Seip patients, are diabetic but normalization of glucose tolerance and significant reduction in circulating insulin fails to alter their skeletal phenotype. Importantly, the skeletal phenotype of FF mice is completely rescued by transplantation of adipocyte precursors or white or brown fat depots, indicating that adipocyte derived products regulate bone mass. Confirming such is the case, transplantation of fat derived from adiponectin and leptin double knockout mice, unlike that obtained from their WT counterparts, fails to normalize FF bone. These observations suggest a paucity of leptin and adiponectin may contribute to the increased bone mass of Berardinelli-Seip patients.
Keyphrases
- adipose tissue
- bone mineral density
- fatty acid
- insulin resistance
- end stage renal disease
- type diabetes
- ejection fraction
- newly diagnosed
- chronic kidney disease
- soft tissue
- bone loss
- postmenopausal women
- prognostic factors
- bone regeneration
- stem cells
- skeletal muscle
- mesenchymal stem cells
- patient reported outcomes
- patient reported
- bone marrow